HomeInsightsPE

Ambalal Sarabhai Enterprises Ltd PE Ratio

Ambalal Sarabhai Enterprises Ltd PE Ratio

stocks purchased

₹ 1.1 Cr

Volume Transacted

(Dec 13, 2024)

stocks purchased

173.5 K

Stocks Traded

(Dec 13, 2024)

Last Updated on: Dec 14, 2024

Image

Ambalal Sarabhai Enterprises Ltd

NSE: AMBASARABH

PE

36.9

Last updated on: Dec 14, 2024

Key Highlights

  • The P/E Ratio of Ambalal Sarabhai Enterprises Ltd is 36.9 as of 14 Dec 13:05 PM .
  • The P/E Ratio of Ambalal Sarabhai Enterprises Ltd changed from 26 on March 2019 to 61.5 on March 2024 . This represents a CAGR of 15.43% over 6 years.
  • The Latest Trading Price of Ambalal Sarabhai Enterprises Ltd is ₹ 64.13 as of 13 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Ambalal Sarabhai Enterprises Ltd

No data available

Company Fundamentals for Ambalal Sarabhai Enterprises Ltd

No data available

Image

Ambalal Sarabhai Enterprises Ltd

NSE: AMBASARABH

Share Price

₹ 64.13

-1.44 (-2.20%)

stock direction

Last updated on: Dec 13, 2024

Market Price of Ambalal Sarabhai Enterprises Ltd

1M

1Y

3Y

5Y

Monitoring Ambalal Sarabhai Enterprises Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Dec 202464.13
12 Dec 202465.57
11 Dec 202465.16
10 Dec 202465.9
09 Dec 202460.05
06 Dec 202458.37
05 Dec 202457.99
04 Dec 202457.73
03 Dec 202458.42
02 Dec 202458.72

SWOT Analysis Of Ambalal Sarabhai Enterprises Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ambalal Sarabhai Enterprises Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Ambalal Sarabhai Enterprises Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Ambalal Sarabhai Enterprises Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Ambalal Sarabhai Enterprises Ltd

No data available

* All values are in crore

Historical Revenue of Ambalal Sarabhai Enterprises Ltd

No data available

* All values are in crore

Historical EBITDA of Ambalal Sarabhai Enterprises Ltd

No data available

* All values are in crore

Historical Net Profit of Ambalal Sarabhai Enterprises Ltd

No data available

* All values are in crore

Historical Dividend Payout of Ambalal Sarabhai Enterprises Ltd

No data available

* All values are in %

About Ambalal Sarabhai Enterprises Ltd

  • Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses.
  • Each subsidiary is a distinct entity contributing its unique expertise and capabilities.
  • It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally.
  • ASE's strength is to lead with cutting edge technology by creating strategic technology tie-ups and collaborative partnerships through our broad national and international networks The Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments.
  • It operates in two segments, pharmaceuticals and electronics.

Ambalal Sarabhai Enterprises Ltd News Hub

News

Ambalal Sarabhai Enterprises reports consolidated net profit of Rs 0.35 crore in the June 2024 quarter

Net profit of Ambalal Sarabhai Enterprises reported to Rs 0.35 crore in the quarter ended ...

Read more

2024-08-09 00:00:00

News

Ambalal Sarabhai Enterprises announces board meeting date

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

2024-08-03 00:00:00

News

Ambalal Sarabhai Enterprises to convene board meeting

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

2024-11-05 00:00:00

News

Ambalal Sarabhai Enterprises consolidated net profit rises 142.59% in the September 2024 quarter

Net profit of Ambalal Sarabhai Enterprises rose 142.59% to Rs 2.62 crore in the quarter en...

Read more

2024-11-13 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Ambalal Sarabhai Enterprises Ltd

What is the current PE Ratio of Ambalal Sarabhai Enterprises Ltd?

The Current PE Ratio of Ambalal Sarabhai Enterprises Ltd is 36.86 as on 14 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 14 Dec 2024.

What was the PE Ratio of Ambalal Sarabhai Enterprises Ltd last year?

The PE Ratio of Ambalal Sarabhai Enterprises Ltd was 13.77 last year, now the PE ratio is 36.86, showing a year-on-year growth of 167.7%.

What does the PE Ratio of Ambalal Sarabhai Enterprises Ltd indicate about its stock?

The PE Ratio of Ambalal Sarabhai Enterprises Ltd is 36.86. This ratio indicates that investors are willing to pay 36.86 times the earnings per share for each share of Ambalal Sarabhai Enterprises Ltd.

What is the PE Ratio Growth of Ambalal Sarabhai Enterprises Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Ambalal Sarabhai Enterprises Ltd grew by 167.7% whereas, the EPS ratio grew by 580.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions